Boston Scientific expects 2025 adjusted profit of $2.95 to $2.99 per share, up from the prior view of $2.87 to $2.94 earlier.

Revenue from the analytics segment, which chiefly depends on a subscription model, climbed 11% to $888 million in the second ...

WASHINGTON (Reuters) -U.S. President Donald Trump has created a lot of leverage on trade with his letters on tariff rates, ...

(Reuters) -NextEra Energy beat Wall Street estimates for second-quarter adjusted profit on Wednesday, helped by strength in ...

GE Vernova, which became independent last year after a three-way split of General Electric, raised its free cash flow target ...

All 105 economists said the Fed, which last cut its key interest rate to 4.25%-4.50% in December, will hold rates again at ...

BRUSSELS (Reuters) -The European Commission will not ask Alphabet, Amazon, Apple, ByteDance, Meta Platforms and Microsoft to ...

BRUSSELS (Reuters) -The European Commission plans to submit counter-tariffs on 93 billion euros ($109 billion) of U.S. goods ...

(Reuters) -Business payments firm Corpay said on Wednesday it would buy British financial services provider Alpha Group in a ...

MUMBAI (Reuters) -India's economy continues to hold up against a global flux, dealing with the impact of geopolitical ...

Profit attributable to CME shareholders was $1.01 billion, or $2.81 per share, for the three months ended June 30, compared ...

“There was a sentiment shift from waiting for certainty to dealing with uncertainty, because you can’t just keep waiting," ...